TRIM
CVS icon

Thompson Rubinstein Investment Management’s CVS Health CVS Stock Holding History

Thompson Rubinstein Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$3.02M Buy
55,964
+8,870
+19% +$547K 0.97% 38
2018
Q4 		$3.09M Sell
47,094
-3,291
-7% -$246K 1.14% 35
2018
Q3 		$3.97M Sell
50,385
-240
-0.5% -$17.2K 1.22% 34
2018
Q2 		$3.26M Buy
50,625
+6,889
+16% +$454K 1.09% 36
2018
Q1 		$2.72M Buy
43,736
+1,010
+2% +$72.5K 0.93% 37
2017
Q4 		$3.1M Buy
42,726
+2,300
+6% +$167K 1.02% 36
2017
Q3 		$3.29M Buy
40,426
+955
+2% +$75.5K 1.15% 35
2017
Q2 		$3.18M Sell
39,471
-175
-0.4% -$13.8K 1.17% 35
2017
Q1 		$3.11M Buy
39,646
+3,159
+9% +$252K 1.13% 37
2016
Q4 		$2.88M Buy
36,487
+13,265
+57% +$1.07M 1.07% 37
2016
Q3 		$2.07M Hold
23,222
– – 0.78% 41
2016
Q2 		$2.22M Buy
23,222
+410
+2% +$40.9K 0.87% 39
2016
Q1 		$2.37M Hold
22,812
– – 0.96% 37
2015
Q4 		$2.23M Hold
22,812
– – 1.02% 34
2015
Q3 		$2.2M Hold
22,812
– – 0.98% 40
2015
Q2 		$2.39M Sell
22,812
-280
-1% -$28.6K 0.95% 41
2015
Q1 		$2.38M Hold
23,092
– – 0.93% 42
2014
Q4 		$2.22M Hold
23,092
– – 0.85% 42
2014
Q3 		$1.84M Hold
23,092
– – 0.72% 43
2014
Q2 		$1.74M Hold
23,092
– – 0.66% 46
2014
Q1 		$1.73M Hold
23,092
– – 0.69% 44
2013
Q4 		$1.65M Hold
23,092
– – 0.65% 46
2013
Q3 		$1.31M Buy
23,092
+530
+2% +$31.6K 0.55% 46
2013
Q2 		$1.29M Buy
+22,562
New +$1.31M 0.58% 46

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Thompson Rubinstein Investment Management's CVS Position: Q1 2019 in Review

Thompson Rubinstein Investment Management increased its CVS Health (CVS) stake by 19% in Q1 2019, buying an estimated $547K and bringing the position to 55,964 shares worth $3.02M. The position accounts for 0.97% of the portfolio, ranked #38.

Thompson Rubinstein Investment Management first reported a position in CVS in Q2 2013 and has held it in 24 quarters since. The position peaked at $3.97M in Q3 2018. 1,707 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

  • Thompson Rubinstein Investment Management held 55,964 shares of CVS Health worth $3.02M as of Q1 2019.
  • Thompson Rubinstein Investment Management bought 8,870 CVS Health shares in Q1 2019, an estimated $547K.
  • CVS Health made up 0.97% of Thompson Rubinstein Investment Management's portfolio in Q1 2019, its #38 holding.
  • Thompson Rubinstein Investment Management first reported a position in CVS Health in Q2 2013 and has held it in 24 quarters since.
  • Thompson Rubinstein Investment Management's CVS Health position peaked at $3.97M in Q3 2018.
  • 1,707 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on Thompson Rubinstein Investment Management's 13F filing for Q1 2019, filed 4 Apr 2019.